Cargando…

2-Oxoester Phospholipase A(2) Inhibitors with Enhanced Metabolic Stability

2-Oxoesters constitute an important class of potent and selective inhibitors of human cytosolic phospholipase A(2) (GIVA cPLA(2)) combining an aromatic scaffold or a long aliphatic chain with a short aliphatic chain containing a free carboxylic acid. Although highly potent 2-oxoester inhibitors of G...

Descripción completa

Detalles Bibliográficos
Autores principales: Koutoulogenis, Giorgos S., Kokotou, Maroula G., Hayashi, Daiki, Mouchlis, Varnavas D., Dennis, Edward A., Kokotos, George
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7175278/
https://www.ncbi.nlm.nih.gov/pubmed/32213911
http://dx.doi.org/10.3390/biom10030491
_version_ 1783524800761692160
author Koutoulogenis, Giorgos S.
Kokotou, Maroula G.
Hayashi, Daiki
Mouchlis, Varnavas D.
Dennis, Edward A.
Kokotos, George
author_facet Koutoulogenis, Giorgos S.
Kokotou, Maroula G.
Hayashi, Daiki
Mouchlis, Varnavas D.
Dennis, Edward A.
Kokotos, George
author_sort Koutoulogenis, Giorgos S.
collection PubMed
description 2-Oxoesters constitute an important class of potent and selective inhibitors of human cytosolic phospholipase A(2) (GIVA cPLA(2)) combining an aromatic scaffold or a long aliphatic chain with a short aliphatic chain containing a free carboxylic acid. Although highly potent 2-oxoester inhibitors of GIVA cPLA(2) have been developed, their rapid degradation in human plasma limits their pharmaceutical utility. In an effort to address this problem, we designed and synthesized two new 2-oxoesters introducing a methyl group either on the α-carbon to the oxoester functionality or on the carbon carrying the ester oxygen. We studied the in vitro plasma stability of both derivatives and their in vitro inhibitory activity on GIVA cPLA(2). Both derivatives exhibited higher plasma stability in comparison with the unsubstituted compound and both derivatives inhibited GIVA cPLA(2), however to different degrees. The 2-oxoester containing a methyl group on the α-carbon atom to the oxoester functionality exhibits enhancement of the metabolic stability and retains considerable inhibitory potency.
format Online
Article
Text
id pubmed-7175278
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-71752782020-04-28 2-Oxoester Phospholipase A(2) Inhibitors with Enhanced Metabolic Stability Koutoulogenis, Giorgos S. Kokotou, Maroula G. Hayashi, Daiki Mouchlis, Varnavas D. Dennis, Edward A. Kokotos, George Biomolecules Article 2-Oxoesters constitute an important class of potent and selective inhibitors of human cytosolic phospholipase A(2) (GIVA cPLA(2)) combining an aromatic scaffold or a long aliphatic chain with a short aliphatic chain containing a free carboxylic acid. Although highly potent 2-oxoester inhibitors of GIVA cPLA(2) have been developed, their rapid degradation in human plasma limits their pharmaceutical utility. In an effort to address this problem, we designed and synthesized two new 2-oxoesters introducing a methyl group either on the α-carbon to the oxoester functionality or on the carbon carrying the ester oxygen. We studied the in vitro plasma stability of both derivatives and their in vitro inhibitory activity on GIVA cPLA(2). Both derivatives exhibited higher plasma stability in comparison with the unsubstituted compound and both derivatives inhibited GIVA cPLA(2), however to different degrees. The 2-oxoester containing a methyl group on the α-carbon atom to the oxoester functionality exhibits enhancement of the metabolic stability and retains considerable inhibitory potency. MDPI 2020-03-24 /pmc/articles/PMC7175278/ /pubmed/32213911 http://dx.doi.org/10.3390/biom10030491 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Koutoulogenis, Giorgos S.
Kokotou, Maroula G.
Hayashi, Daiki
Mouchlis, Varnavas D.
Dennis, Edward A.
Kokotos, George
2-Oxoester Phospholipase A(2) Inhibitors with Enhanced Metabolic Stability
title 2-Oxoester Phospholipase A(2) Inhibitors with Enhanced Metabolic Stability
title_full 2-Oxoester Phospholipase A(2) Inhibitors with Enhanced Metabolic Stability
title_fullStr 2-Oxoester Phospholipase A(2) Inhibitors with Enhanced Metabolic Stability
title_full_unstemmed 2-Oxoester Phospholipase A(2) Inhibitors with Enhanced Metabolic Stability
title_short 2-Oxoester Phospholipase A(2) Inhibitors with Enhanced Metabolic Stability
title_sort 2-oxoester phospholipase a(2) inhibitors with enhanced metabolic stability
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7175278/
https://www.ncbi.nlm.nih.gov/pubmed/32213911
http://dx.doi.org/10.3390/biom10030491
work_keys_str_mv AT koutoulogenisgiorgoss 2oxoesterphospholipasea2inhibitorswithenhancedmetabolicstability
AT kokotoumaroulag 2oxoesterphospholipasea2inhibitorswithenhancedmetabolicstability
AT hayashidaiki 2oxoesterphospholipasea2inhibitorswithenhancedmetabolicstability
AT mouchlisvarnavasd 2oxoesterphospholipasea2inhibitorswithenhancedmetabolicstability
AT dennisedwarda 2oxoesterphospholipasea2inhibitorswithenhancedmetabolicstability
AT kokotosgeorge 2oxoesterphospholipasea2inhibitorswithenhancedmetabolicstability